New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
07:33 EDTBIIBBiogen to present Plegridy, Tecfidera data at AAN annual meeting
Biogen Idec will present more than 60 company-sponsored platform and poster presentations on data supporting its marketed and investigational therapies for neurological diseases at the 66th American Academy of Neurology, or AAN, Annual Meeting in Philadelphia, April 26-May 3. Data at AAN will include results from studies of its currently marketed products, TECFIDERA, TYSABRI, AVONEX and FAMPYRA, as well as findings from the clinical programs of its MS pipeline candidates PLEGRIDY, daclizumab high-yield process and Anti-LINGO-1.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 12, 2014
08:01 EDTBIIBPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
December 9, 2014
12:22 EDTBIIBPiper Jaffray biopharm analyst holds an analyst/industry conference call
Senior Research Analyst Schimmer, along with Biopharmaceuticals Analyst Breazzano, discuss gene therapy for hemophilia on an Analyst/Industry conference call to be held on December 11 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use